Inventor · disambiguated record
Hung-Sen Lai
Also filed as: LAI HUNG-SEN
37 granted patents·30 pending applications·156 citations·filing 1997–2025
97Inventor score
Top patents by PatentIndex Score
67 records- 0197US10517955B2FAP-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2018·Granted Dec 31, 2019·9 cites·18 claims
- 0297US9956297B2FAP-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2016·Granted May 1, 2018·10 cites·18 claims
- 0396US11266669B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2020·Granted Mar 8, 2022·4 cites·39 claims
- 0496US9597410B2FAP-activated proteasome inhibitors for treating solid tumorsBACHOVCHIN WILLIAM W·Filed 2012·Granted Mar 21, 2017·16 cites·27 claims
- 0595US11957657B2Combination therapies using immuno-dash inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2021·Granted Apr 16, 2024·2 cites·17 claims
- 0695US11096924B2Combination therapies using immuno-dash inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2017·Granted Aug 24, 2021·6 cites·29 claims
- 0795US9737556B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2015·Granted Aug 22, 2017·8 cites·8 claims
- 0894US10117887B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2017·Granted Nov 6, 2018·6 cites·39 claims
- 0993US10709722B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2018·Granted Jul 14, 2020·5 cites·33 claims
- 1092US7994121B2Stable analogs of peptide and polypeptide therapeuticsTUFTS COLLEGE·Filed 2007·Granted Aug 9, 2011·16 cites·17 claims
- 1191US11583516B2Dash inhibitors, and uses related theretoTUFTS COLLEGE·Filed 2017·Granted Feb 21, 2023·3 cites·18 claims
- 1289US12478609B2Combination therapies using immuno-DASH inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2024·Granted Nov 25, 2025·0 cites·18 claims
- 1389US8268880B2Soft protease inhibitors and pro-soft forms thereofBACHOVCHIN WILLIAM W·Filed 2006·Granted Sep 18, 2012·9 cites·16 claims
- 1489US7259234B2Stable analogs of peptide and polypeptide therapeuticsTUFTS COLLEGE·Filed 2004·Granted Aug 21, 2007·25 cites·6 claims
- 1588US10245248B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2015·Granted Apr 2, 2019·5 cites·11 claims
- 1688US2025108031A1Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 1787US11065339B2FAP-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2019·Granted Jul 20, 2021·1 cites·10 claims
- 1887US2024398842A1Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 1986US11559537B2Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonistsTUFTS COLLEGE·Filed 2018·Granted Jan 24, 2023·2 cites·24 claims
- 2086US8933056B2Soft protease inhibitors and pro-soft forms thereofTUFTS COLLEGE·Filed 2013·Granted Jan 13, 2015·5 cites·3 claims
- 2186US7998997B2Inhibitors of fibroblast activation protein alphaTUFTS COLLEGE·Filed 2006·Granted Aug 16, 2011·7 cites·7 claims
- 2285US11033525B2Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2019·Granted Jun 15, 2021·1 cites·12 claims
- 2383US8889720B2Non-flushing niacin analogues, and methods of use thereofTUFTS COLLEGE·Filed 2012·Granted Nov 18, 2014·4 cites·34 claims
- 2483US2023390241A1Dash inhibitors, and uses related theretoTUFTS COLLEGE·Filed 2023·Application pending·0 cites
- 2580US11925655B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 2679US12214047B2FAP-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2021·Granted Feb 4, 2025·0 cites·21 claims
- 2779US9193708B2Non-flushing niacin analogues, and methods of use thereofTUFTS COLLEGE·Filed 2014·Granted Nov 24, 2015·2 cites·10 claims
- 2879US8377971B2Non-flushing niacin analogues, and methods of use thereofTUFTS COLLEGE·Filed 2007·Granted Feb 19, 2013·2 cites·8 claims
- 2979US2025367304A1Fap-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2025·Application pending·0 cites
- 3077US12053450B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2021·Granted Aug 6, 2024·0 cites·17 claims
- 3176US12121505B2Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2021·Granted Oct 22, 2024·0 cites·10 claims
- 3276US12023316B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2021·Granted Jul 2, 2024·0 cites·20 claims
- 3374US8937063B2Niacin mimetics, and methods of use thereofBACHOVCHIN WILLIAM W·Filed 2011·Granted Jan 20, 2015·3 cites·29 claims
- 3473US9511060B2Non-flushing niacin analogues, and methods of use thereofTUFTS COLLEGE·Filed 2015·Granted Dec 6, 2016·1 cites·23 claims
- 3573US9212142B2Niacin mimetics, and methods of use thereofTUFTS COLLEGE·Filed 2013·Granted Dec 15, 2015·2 cites·24 claims
- 3673US8450316B2Niacin mimetics, and methods of use thereofBACHOVCHIN WILLIAM W·Filed 2011·Granted May 28, 2013·2 cites·6 claims
- 3772US11707539B2FAP-targeted radiopharmaceuticals and imaging agents, and uses related theretoTUFTS COLLEGE·Filed 2021·Granted Jul 25, 2023·0 cites·22 claims
- 3872US2023330275A1Fap-targeted radiopharmaceuticals and imaging agents, and uses related theretoTUFTS COLLEGE·Filed 2022·Application pending·0 cites
- 3966US9192646B2Soft protease inhibitors and pro-soft forms thereofTUFTS COLLEGE·Filed 2014·Granted Nov 24, 2015·0 cites·17 claims
- 4066US2009062235A1Inhibitors of Dipeptidylpeptidase IVTUFTS COLLEGE·Filed 2008·Application pending·0 cites
- 4165US2024366807A1Radiofluorinated agents for pet imaging selectively targeting fibroblast activation proteinTUFTS COLLEGE·Filed 2022·Application pending·0 cites
- 4264US2023372372A1Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonistsTUFTS COLLEGE·Filed 2023·Application pending·0 cites
- 4364US2024408408A1Fap-targeted neutron capture agents, and uses and formulations related theretoTUFTS COLLEGE·Filed 2022·Application pending·0 cites
- 4462US8563533B2Soft protease inhibitors and pro-soft forms thereofBACHOVCHIN WILLIAM W·Filed 2012·Granted Oct 22, 2013·0 cites·25 claims
- 4561US2024207292A1Boronic acid compounds, compositions and methodsTUFTS COLLEGE·Filed 2022·Application pending·0 cites
- 4660US2014018545A1Inhibitors of Dipeptidylpeptidase IVBACHOVCHIN WILLIAM W·Filed 2013·Application pending·0 cites
- 4760US2022211883A1Fap-activated radiotheranostics and uses related theretoTUFTS COLLEGE·Filed 2021·Application pending·0 cites
- 4857US9102756B2Stable analogs of peptide and polypeptide therapeuticsBACHOVCHIN WILLIAM W·Filed 2011·Granted Aug 11, 2015·0 cites·15 claims
- 4957US2005203027A1Inhibitors of dipeptidylpeptidase IVTUFTS COLLEGE·Filed 2005·Application pending·0 cites
- 5056US2016250237A1Soft protease inhibitors and pro-soft forms thereofTUFTS COLLEGE·Filed 2015·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hung-Sen Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →